To Determine the Best Feeding Practice in Preterm Infants on Non-invasive Ventilation.
Launched by RAJEEV KUMAR · Apr 11, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at the best way to feed preterm infants who need help breathing. Specifically, it is comparing two different feeding methods: continuous gavage feeds (which means feeding slowly through a tube) versus bolus feeds (feeding larger amounts at once) in infants who are on non-invasive breathing support, like a special kind of nasal prongs. The goal is to find out which method helps these babies reach full feeding quicker.
To be eligible for this study, infants must be born very early, between 24 and 34 weeks of pregnancy, and should be on non-invasive breathing support. They should also be receiving little or no feeding at the time they join the trial. If your baby meets these criteria, they might be able to participate. Families can expect close monitoring during the feeding process, and the trial is currently looking for participants. This study is important because it may help improve feeding practices for some of the smallest and most vulnerable infants.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Preterm Infants 24- 34 weeks of gestation
- • 2. On Non-invasive ventilation (NIPPV/CPAP/HFNC)
- • 3. Nothing by mouth (NPO) or on trophic feeds (\<20 ml/kg/day) at the time of randomization.
- Exclusion Criteria:
- • 1. Gestational Age \> 34 weeks
- • 2. Infants on invasive ventilation or low flow nasal cannula and on feeding volume more than trophic feeds.
- • 3. Major congenital anomalies.
About Rajeev Kumar
Dr. Rajeev Kumar is a distinguished clinical trial sponsor with extensive expertise in advancing medical research and innovation. With a strong background in clinical pharmacology and regulatory affairs, he is committed to facilitating the development of novel therapeutics through rigorously designed clinical trials. Dr. Kumar's leadership emphasizes patient safety, data integrity, and compliance with regulatory standards, ensuring that each study contributes valuable insights to the medical community. His collaborative approach fosters strong partnerships with research institutions and healthcare professionals, driving forward the mission to enhance patient outcomes and improve health care practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
Patients applied
Trial Officials
Rajeev Kumar, MD
Principal Investigator
Cook County Health
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported